Mannkind (MNKD) Net Margin (2010 - 2026)

Mannkind's (MNKD) quarterly Net Margin came in at 18.43% in Q1 2026, down 3522.0% year-on-year from 0.54% in Q1 2025, and down 29.38% on a QoQ basis from 14.25% in Q4 2025.

Mannkind (MNKD) Net Margin (2010 - 2026) Analysis & Trends

Mannkind (MNKD) has 14 years of Net Margin data on file, last reported at 18.43% in Q1 2026.

  • On a quarterly basis, Net Margin fell 3522.0% year-over-year to 18.43% in Q1 2026; TTM through Mar 2026 was 6.64%, a 1675.0% decrease from a year earlier, with the FY2025 full-year figure at 1.68%, down 798.0% from the prior year.
  • Net Margin for Q1 2026 stood at 18.43%, down from 14.25% in the prior quarter.
  • Over the last five years, Net Margin for MNKD reached as high as 16.79% in Q1 2025 and fell as low as 216.79% in Q1 2022.
  • Historically, Net Margin has averaged 26.8% across 5 years, with a median of 2.78% in 2024.
  • Across the five-year window, Net Margin plunged 14272 bps in 2022 and jumped 19268 bps in 2023, its largest moves.
  • Year by year, Net Margin stood at 49.77% in 2022, then soared by 105 bps to 2.41% in 2023, then soared by 301 bps to 9.66% in 2024, then sank by 247 bps to 14.25% in 2025, then decreased by 29 bps to 18.43% in 2026.
  • Per Business Quant data, the three most recent Net Margin figures were 18.43% in Q1 2026, 14.25% in Q4 2025, and 9.72% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Mannkind 1.20 Bn 1.07 Bn 82.66 Mn -18.43%

Historic Data

Download Data
DateValue
Mar 31, 2026 -18.43%
Dec 31, 2025 -14.25%
Sep 30, 2025 9.72%
Jun 30, 2025 0.84%
Mar 31, 2025 16.79%
Dec 31, 2024 9.66%
Sep 30, 2024 16.48%
Jun 30, 2024 -2.78%
Mar 31, 2024 16.04%
Dec 31, 2023 2.41%
Sep 30, 2023 6.98%
Jun 30, 2023 -10.83%
Mar 31, 2023 -24.11%
Dec 31, 2022 -49.77%
Sep 30, 2022 -43.97%
Jun 30, 2022 -153.61%
Mar 31, 2022 -216.79%
Dec 31, 2021 -224.22%
Sep 30, 2021 -19.93%
Jun 30, 2021 -152.59%